Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed ...

What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...

"Our findings open avenues for biomarkers of therapy response and acquired drug resistance to help guide clinical decisions in individual patients with metastatic prostate cancer throughout the course ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong ...

At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made ...

A novel theranostic approach that targets RET -- a newly identified biomarker for neuroendocrine prostate cancer enables high ...

Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical textbooks present as relatively binary: remove the entire prostate gland or ...

Extracellular vesicles shed by prostate cancer cells to the bloodstream contain tumor-derived material that can be used as biomarkers of therapy response and resistance in patients with metastatic ...